Bayer Notches Dual EYLEA 8mg Wins With China nAMD Approval and EU 6-Month Interval Extension
High-dose aflibercept secured a regulatory victory in China as 6-month dosing nears European approval Good news apparently comes in twos…
FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval
Regeneron’s proposal to lengthen EYLEA HD dosing intervals to 24 weeks hits a CRL roadblock. The wait for extended treatment…
latest posts